Southwest Oncology Group 0408: Phase II trial of neoadjuvant capecitabine/oxaliplatin/bevacizumab for resectable colorectal metastases in the liver.

Southwest Oncology Group 0408: Phase II trial of neoadjuvant capecitabine/oxaliplatin/bevacizumab for resectable colorectal metastases in the liver. Clin Colorectal Cancer. 2006 Mar; 5(6):436-9.

View in: PubMed

subject areas

Antibodies, Monoclonal
Antibodies, Monoclonal, Humanized
Antineoplastic Agents
Bevacizumab
Capecitabine
Clinical Trials, Phase II as Topic
Colorectal Neoplasms
Deoxycytidine
Drug Administration Schedule
Fluorouracil
Humans
Liver Neoplasms
Multicenter Studies as Topic
Neoadjuvant Therapy
Organoplatinum Compounds
Patient Selection
Southwestern United States

authors with profiles

JEAN NICOLAS VAUTHEY
CATHY ENG